本页面由Tiger Trade Technology Pte. Ltd.提供服务

Adaptive Biotechnologies Corp

14.22
-0.3000-2.07%
盘后14.01-0.2100-1.48%18:56 EDT
成交量:210.98万
成交额:2,974.79万
市值:21.87亿
市盈率:-36.26
高:14.39
开:14.38
低:13.81
收:14.52
52周最高:20.76
52周最低:6.68
股本:1.54亿
流通股本:1.17亿
量比:1.01
换手率:1.80%
股息:- -
股息率:- -
每股收益(TTM):-0.3922
每股收益(LYR):-0.3922
净资产收益率:-27.82%
总资产收益率:-6.79%
市净率:9.99
市盈率(LYR):-36.26

数据加载中...

2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/06

重要事件披露

Form 8-K - Current report
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

重要事件披露

Form 8-K - Current report